336 related articles for article (PubMed ID: 27147589)
1. Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.
Vannella KM; Ramalingam TR; Borthwick LA; Barron L; Hart KM; Thompson RW; Kindrachuk KN; Cheever AW; White S; Budelsky AL; Comeau MR; Smith DE; Wynn TA
Sci Transl Med; 2016 May; 8(337):337ra65. PubMed ID: 27147589
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma.
An G; Wang W; Zhang X; Huang Q; Li Q; Chen S; Du X; Corrigan CJ; Huang K; Wang W; Chen Y; Ying S
Respirology; 2020 Jun; 25(6):603-612. PubMed ID: 31610614
[TBL] [Abstract][Full Text] [Related]
3. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.
Stier MT; Bloodworth MH; Toki S; Newcomb DC; Goleniewska K; Boyd KL; Quitalig M; Hotard AL; Moore ML; Hartert TV; Zhou B; McKenzie AN; Peebles RS
J Allergy Clin Immunol; 2016 Sep; 138(3):814-824.e11. PubMed ID: 27156176
[TBL] [Abstract][Full Text] [Related]
5. TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation.
Toki S; Goleniewska K; Zhang J; Zhou W; Newcomb DC; Zhou B; Kita H; Boyd KL; Peebles RS
Allergy; 2020 Jul; 75(7):1606-1617. PubMed ID: 31975538
[TBL] [Abstract][Full Text] [Related]
6. The potential role of interleukin (IL)-25/IL-33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis.
Xu X; Dai H; Zhang J
Clin Respir J; 2022 Nov; 16(11):696-707. PubMed ID: 36082495
[TBL] [Abstract][Full Text] [Related]
7. Intelectin contributes to allergen-induced IL-25, IL-33, and TSLP expression and type 2 response in asthma and atopic dermatitis.
Yi L; Cheng D; Zhang K; Huo X; Mo Y; Shi H; Di H; Zou Y; Zhang H; Zhao J; Xu Y; Erle DJ; Zhen G
Mucosal Immunol; 2017 Nov; 10(6):1491-1503. PubMed ID: 28224996
[TBL] [Abstract][Full Text] [Related]
8. A tissue checkpoint regulates type 2 immunity.
Van Dyken SJ; Nussbaum JC; Lee J; Molofsky AB; Liang HE; Pollack JL; Gate RE; Haliburton GE; Ye CJ; Marson A; Erle DJ; Locksley RM
Nat Immunol; 2016 Dec; 17(12):1381-1387. PubMed ID: 27749840
[TBL] [Abstract][Full Text] [Related]
9. Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.
Mizutani N; Sae-Wong C; Kangsanant S; Nabe T; Yoshino S
Immunology; 2015 Dec; 146(4):568-81. PubMed ID: 26310839
[TBL] [Abstract][Full Text] [Related]
10. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite.
Chen ZG; Zhang TT; Li HT; Chen FH; Zou XL; Ji JZ; Chen H
PLoS One; 2013; 8(1):e51268. PubMed ID: 23300949
[TBL] [Abstract][Full Text] [Related]
12. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
[TBL] [Abstract][Full Text] [Related]
13. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ.
Ramalingam TR; Gieseck RL; Acciani TH; M Hart K; Cheever AW; Mentink-Kane MM; Vannella KM; Wynn TA
J Pathol; 2016 Jul; 239(3):344-54. PubMed ID: 27125685
[TBL] [Abstract][Full Text] [Related]
15. Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses.
Zhou B; Headley MB; Aye T; Tocker J; Comeau MR; Ziegler SF
J Immunol; 2008 Nov; 181(9):6557-62. PubMed ID: 18941246
[TBL] [Abstract][Full Text] [Related]
16. Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by
Maggi L; Camelo GMA; Rocha IC; Pereira Alves W; Moreira JMP; Almeida Pereira T; Tafuri WL; Rabelo ÉML; Correa A; Ecco R; Negrão-Corrêa DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373379
[No Abstract] [Full Text] [Related]
17. IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure.
Iijima K; Kobayashi T; Hara K; Kephart GM; Ziegler SF; McKenzie AN; Kita H
J Immunol; 2014 Aug; 193(4):1549-59. PubMed ID: 25015831
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells.
Li YL; Li HJ; Ji F; Zhang X; Wang R; Hao JQ; Bi WX; Dong L
J Asthma; 2010 Mar; 47(2):117-23. PubMed ID: 20170316
[TBL] [Abstract][Full Text] [Related]
19. Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin.
Ramalingam TR; Pesce JT; Mentink-Kane MM; Madala S; Cheever AW; Comeau MR; Ziegler SF; Wynn TA
J Immunol; 2009 May; 182(10):6452-9. PubMed ID: 19414799
[TBL] [Abstract][Full Text] [Related]
20. Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model.
Sugita J; Asada Y; Ishida W; Iwamoto S; Sudo K; Suto H; Matsunaga T; Fukuda K; Fukushima A; Yokoi N; Ohno T; Azuma M; Ebihara N; Saito H; Kubo M; Nakae S; Matsuda A
Immun Inflamm Dis; 2017 Dec; 5(4):515-525. PubMed ID: 28730605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
